Abstract
The molecular salt, 2-methylpyridinium 5-(2,4-dinitrophenyl)-2,6-dioxo-1,2,3,6-tetrahydropy-rimidin-4-olate) (I), is prepared from the ethanolic solution of 1-chloro-2,4-dinitrobenzene, pyrimidine-2,4,6-(1H,3H,5H)-trione (barbituric acid) and 2-methylpyridine at room temperature, and the molecular salt, pyridinium 5-(2,4-dinitrophenyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate (II), is prepared from the same reactants, by dissolving them in hot DMSO and ethanol mixture at 70°C. The structures of I and II are characterized by visible, IR, 1H-NMR, 13C-NMR and elemental analysis and confirmed by single crystal X-ray analysis. Both the salts crystallize in triclinic crystal system with sp. gr. \(P\bar 1\). They possess noticeable anticonvulsant activity even at low concentration (25 mg/kg). Acute toxicity studies of these complexes indicate that LD50 values are greater than 1500 mg/kg and the tested animals do not show any behavioural changes.
Similar content being viewed by others
References
C. J. Jackson and F. H. Gazzolo, J. Am. Chem. Soc. 23, 376 (1900).
E. Buncel, A. R. Norris, and K. E. Russell, Quart. Rev. Chem. Soc. 22, 123 (1968).
F. Terrier, Chem. Rev. 82, 77 (1982).
R. O. Al-Kaysi, J. I. Bourdelande, I. Gallardo, G. Guirado, and J. Hernando, Chem. Eur. J. 13, 7066 (2007).
R. O. Al-Kaysi, I. Gallardo, and G. Guirado, Molecules 13, 1282 (2008).
K. Balasubramani, D. Kalaivani, R. Malarvizhi, et al., J. Chem. Cryst. 41, 767 (2011).
D. Kalaivani, M. Vasuki, and S. Santhi, Int. J. Chem. Kinet. 43, 467 (2011).
L. M. Gnanadoss and D. Kalaivani, J. Org. Chem. 50, 1174 (1985).
L. M. Gnanadoss and D. Kalaivani, J. Org. Chem. 50, 1178 (1985).
D. Kalaivani, R. Malarvizhi, and R. Subbalakshmi, Med. Chem. Res. 17, 369 (2008).
D. Kalaivani and R. Malarvizhi, Acta Cryst. E65, o2548 (2009).
D. Kalaivani and M. Buvaneswari, Recent Advances in Clinical Medicine UK (WSEAS Publications, 2010), p. 255.
R. BabyKala and D. Kalaivani, Acta Cryst. E68, o541 (2012).
G. Mangaiyarkarasi and D. Kalaivani, Acta Cryst, E69, o592 (2013).
B. Gauthier, Ann. Pharm. Fr. 21, 655 (1963).
L. Moafi, S. Ahadi, and A. Bazgir, Tetrahedron Lett. 51, 6270 (2010).
D. J. Brown, The Chemistry of Hetero Cyclic Compounds, Ed. by A. Weissberger (Interscience, New York, 1962), p. 16.
S. D. Shorvon, The Treatment of Epilepsy (Blackwell Publishers, Oxford, UK, 2004).
S. Nadkarni, J. Lajole, and O. Devinsky. Neurology 64, S2–S11 (2005).
E. R. Feldman, G. Krang, R. N. Praschak, and S. Kasper, Curr. Med. Res. Opin 25, 2281 (2009).
Bruker APEX 2, SAINT-plus and SADABS (Bruker AXS-INC., Madison, Wisconsin, USA, 2004).
A. Altomare, G. Cascarano, C. Giacovazzo, and A. Guagliardi, J. Appl. Cryst. 26, 343 (1993).
G. M. Sheldrick, Acta Cryst. A64, 112 (2008).
C. F. Macrae, I. J. Bruno, J. A. Chisholm, et al., J. Appl. Cryst. 41, 466 (2008).
L. J. Farrugia, J. Appl. Cryst. 30, 565 (1997).
A. K. Misra, P. C. Dandiya, and S. K. Kulkarni, Indian J. Pharmacol. 5, 449 (1974).
S. K. Bhattacharya and A. Chakrabati, Indian J. Exp. Biol. 36, 112 (1998).
P. Armitage, Statistical Methods in Medicinal Research, 1st edition (Blackwell Scientific publications, London, 1971), p. 217.
L. C. Miller and M. L. Trainter, Proc. Soc. Exp. Med. Biol. 57, 261 (1944).
J. ShettyAkhila, S. Deepa, and M. C. alwar, Curr. Sci. 93, 917 (2007).
A. I. Vogel, Text Book of Practical Organic Chemistry (Longman, London, 1978), p. 776.
R. M. Silverstein and F. X. Webster, Spectrometric Identification of Organic Compounds (John Wiley and Sons, Newyork, 2004), p. 103.
E. Ramachandran, K. Baskaran, and S. Natarajan, Cryst. Ref. Technol. 42, 73 (2007).
W. W. Epstein and F. W. Sweat, Chem. Rev. 67, 247 (1967).
W. Kemp, Organic Spectroscopy (Palgrave, Newyork, 1991).
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is published in the original.
Rights and permissions
About this article
Cite this article
Mangaiyarkarasi, G., Kalaivani, D. 2-Methylpyridinium/pyridinium 5-(2,4-dinitrophenyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olates as potent anticonvulsant agents—synthesis and crystal structure. Crystallogr. Rep. 58, 1096–1102 (2013). https://doi.org/10.1134/S1063774513080075
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1063774513080075